2ROMANO L, VENTURI G, GIOMI S, et al. Development and significance of resistance to protease inhibitors in HIV-1 infected adults under triple-drug therapy in clinical practice[J] .J Med Virol,2002,66(2) : 143-150.
3DEEKS SG, SMITH M, HOLODNIY M, et al. HIV-I protease inhibitors. A review for clinicians[J]. JAMA, 1997,277(2):145-153.
4SCHAPIRO JM, WINTERS MA, STEWART F,et al. The effect of high-dose saquinavir on viral load and CD4^+ T-cell counts in HIV-infected patients[J]. Ann Intern Med, 1996,124(12) : 1039-1050.
5LORI F, MALYKH A, CARA A, et al. Hydroxyurea as an inhibitor of human immundeficiency virus type 1 replication[J]. Science, 1994,266 (4) : 801.
6WANG LP, ZHU YH. Clinical effect and adverse reaction of zidovudine for immunodeficiency syndrome[J]. New Drugs Clin Rem(in Chinese), 1996,15( 1 ) :38-40.
7WANG XC. Immunoreaetion and immunotherapy of HIV infection[J]. World Notes: Epidemiol Infect Dis (in Chinese), 2001,28(3) :97-101.
8POWDERLY WG. Current approaches to treatment for HIV-1 infection[J] .J Neurovirol, 2000, 6 Suppl 1 :S8-S13.
9SMITH D. New approaches in the treatment of HIV infection[J].Aust Prescr, 1998,21:44-45.
